Blood Cancer Talks cover image

Episode 3. Management of Waldenström Macroglobulinemia

Blood Cancer Talks

00:00

How to Treat Multiple Myeloma Patients

Waldenstrom is incurable, highly survivals even before the introduction of BTK inhibitors. Having an IgM of 6,000 with the hemoglobin of 11.5 and no hyperviscosity is not an indication for therapy. These patients aren't like CLL. They don't have minus 17p or these very adverse prognostics.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app